$RXO stock has now fallen 9% today, according to our price data from Polygon. There has been approximately $7,866,794 of trading volume.
Here is what we see in our data on $RXO (you can track the company live on Quiver's $RXO stock page):
$RXO Insider Trading Activity
$RXO insiders have traded $RXO stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $RXO stock by insiders over the last 6 months:
- PARTNERS, LP MFN purchased 532,276 shares for an estimated $6,387,312
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$RXO Hedge Fund Activity
We have seen 131 institutional investors add shares of $RXO stock to their portfolio, and 102 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 4,711,584 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $68,883,358
- BOSTON PARTNERS added 2,497,016 shares (+inf%) to their portfolio in Q1 2026, for an estimated $36,506,373
- HOOD RIVER CAPITAL MANAGEMENT LLC added 2,458,725 shares (+123.3%) to their portfolio in Q1 2026, for an estimated $35,946,559
- ORBIS ALLAN GRAY LTD added 1,720,219 shares (+5.0%) to their portfolio in Q1 2026, for an estimated $25,149,601
- FRONTIER CAPITAL MANAGEMENT CO LLC added 1,090,466 shares (+69.9%) to their portfolio in Q1 2026, for an estimated $15,942,612
- KENNEDY CAPITAL MANAGEMENT LLC added 976,475 shares (+135.7%) to their portfolio in Q1 2026, for an estimated $14,276,064
- MORGAN STANLEY removed 962,783 shares (-43.5%) from their portfolio in Q1 2026, for an estimated $14,075,887
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$RXO Analyst Ratings
Wall Street analysts have issued reports on $RXO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stifel issued a "Buy" rating on 05/15/2026
To track analyst ratings and price targets for $RXO, check out Quiver Quantitative's $RXO forecast page.
$RXO Price Targets
Multiple analysts have issued price targets for $RXO recently. We have seen 9 analysts offer price targets for $RXO in the last 6 months, with a median target of $22.0.
Here are some recent targets:
- Ariel Rosa from Citigroup set a target price of $30.0 on 07/09/2026
- Thomas Wadewitz from UBS set a target price of $26.0 on 06/30/2026
- Brandon Oglenski from Barclays set a target price of $28.0 on 06/26/2026
- J. Bruce Chan from Stifel set a target price of $22.0 on 05/15/2026
- Ravi Shanker from Morgan Stanley set a target price of $22.0 on 05/08/2026
- Christian Wetherbee from Wells Fargo set a target price of $22.0 on 05/08/2026
- Bascome Majors from Susquehanna set a target price of $18.0 on 05/08/2026
You can track data on $RXO on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
